Daily low-dose aspirin might protect a subset of older adults against dementia.
These results are from the ASPREE randomized trial.
Low-dose daily aspirin is linked to a 70% lower relative risk of dementia in older adults who carry a specific genetic profile tied to platelet count.
Link to journal paper:
Paper · Alzheimer's & Dementia · 2026Platelet count polygenic scores may modify the effect of aspirin in primary prevention of dementiaINTRODUCTION Aspirin is not recommended for dementia prevention due to limited benefit. We investigated whether genetic subgroups may benefit. METHODS In the ASPirin in Reducing Events in the Elderly (ASPREE) trial ( n = 13,541), we screened 5182 polygenic risk scores (PGSs) for aspirin interactions on dementia and major bleeding. After quality control, 1848 PGSs were analyzed using Cox models for aspirin×PGS…alz-journals.onlinelibrary.wiley.comStudy Overview
- Institution: Monash University researchers analyzed data from the ASPREE Trial (Aspirin in Reducing Events in the Elderly).
- Publication: The findings were published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.
- Participant Scope: Genetic data from over 13,500 healthy older adults was examined.
Key Findings
- Genetic Link: The strongest protective benefit of aspirin against dementia appeared in participants in the highest 20% (top quintile) of a platelet-count polygenic risk score.
- Risk Reduction: In this high-scoring genetic group, 1% of participants taking daily low-dose (100-milligram) aspirin developed dementia, compared to 3.3% of those taking a placebo.
- No Effect Elsewhere: Participants outside of this top genetic tier showed no cognitive benefit from taking aspirin.
Important Caveats and Risks
- Bleeding Risk: Researchers noted that aspirin doubled the risk of major bleeding events in this high genetic score subgroup (4.4% on aspirin versus 2.1% on placebo).
- Need for Validation: These exploratory results are hypothesis-generating and require formal clinical validation before doctors can use genetic screening to prescribe personalized aspirin for dementia prevention.
- Consult a Doctor: Experts warn that individuals should not start taking aspirin to prevent memory loss or cognitive decline without first speaking with a healthcare provider.




